FR351M - Nouvel antibiotique lankavacidine utilisable en thérapeutique. - Google Patents

Nouvel antibiotique lankavacidine utilisable en thérapeutique.

Info

Publication number
FR351M
FR351M FR836984A FR836984A FR351M FR 351 M FR351 M FR 351M FR 836984 A FR836984 A FR 836984A FR 836984 A FR836984 A FR 836984A FR 351 M FR351 M FR 351M
Authority
FR
France
Prior art keywords
lankavacidin
usable
therapy
new antibiotic
antibiotic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
FR836984A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novartis AG
BASF Schweiz AG
Original Assignee
Ciba Geigy AG
Ciba AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from CH7340059A external-priority patent/CH374147A/de
Priority claimed from FR827673A external-priority patent/FR1295910A/fr
Application filed by Ciba Geigy AG, Ciba AG filed Critical Ciba Geigy AG
Priority to FR836984A priority Critical patent/FR351M/fr
Application granted granted Critical
Publication of FR351M publication Critical patent/FR351M/fr
Active legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C12N1/205—Bacterial isolates
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P1/00—Preparation of compounds or compositions, not provided for in groups C12P3/00 - C12P39/00, by using microorganisms or enzymes
    • C12P1/06—Preparation of compounds or compositions, not provided for in groups C12P3/00 - C12P39/00, by using microorganisms or enzymes by using actinomycetales
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P19/00—Preparation of compounds containing saccharide radicals
    • C12P19/44—Preparation of O-glycosides, e.g. glucosides
    • C12P19/60—Preparation of O-glycosides, e.g. glucosides having an oxygen of the saccharide radical directly bound to a non-saccharide heterocyclic ring or a condensed ring system containing a non-saccharide heterocyclic ring, e.g. coumermycin, novobiocin
    • C12P19/62—Preparation of O-glycosides, e.g. glucosides having an oxygen of the saccharide radical directly bound to a non-saccharide heterocyclic ring or a condensed ring system containing a non-saccharide heterocyclic ring, e.g. coumermycin, novobiocin the hetero ring having eight or more ring members and only oxygen as ring hetero atoms, e.g. erythromycin, spiramycin, nystatin
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/465—Streptomyces

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Mycology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Biomedical Technology (AREA)
FR836984A 1959-05-20 1960-08-29 Nouvel antibiotique lankavacidine utilisable en thérapeutique. Active FR351M (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
FR836984A FR351M (fr) 1959-05-20 1960-08-29 Nouvel antibiotique lankavacidine utilisable en thérapeutique.

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
CH7340059A CH374147A (de) 1959-05-20 1959-05-20 Verfahren zur Herstellung eines neuen Antibiotikums
CH127660 1960-02-05
FR827673A FR1295910A (fr) 1960-05-19 1960-05-19 Procédé de préparation de deux nouveaux antibiotiques dénommés <<lankavamycine>> et <<lankavacidine>>, à partir d'une souche de streptomyces
FR836984A FR351M (fr) 1959-05-20 1960-08-29 Nouvel antibiotique lankavacidine utilisable en thérapeutique.

Publications (1)

Publication Number Publication Date
FR351M true FR351M (fr) 1961-03-27

Family

ID=88513714

Family Applications (1)

Application Number Title Priority Date Filing Date
FR836984A Active FR351M (fr) 1959-05-20 1960-08-29 Nouvel antibiotique lankavacidine utilisable en thérapeutique.

Country Status (1)

Country Link
FR (1) FR351M (fr)

Similar Documents

Publication Publication Date Title
FR369M (fr) Halogénotétracyclines.
FR308M (fr) Nouvelle pyridyl-éthyl-guanidine utilisable en thérapeutique.
BE596003A (fr) Amino-hydroxy-nitriles.
FR302M (fr) Nouvelle m-butoxy-phénoxy-éthylamine utilisable en thérapeutique.
FR350M (fr) Nouvel antibiotique lankavamycine utilisable en thérapeutique.
FR1898M (fr) Nouvelle substance utilisable en thérapeutique.
FR352M (fr) Nouvel antibiotique ferrimycine utilisable en thérapeutique.
FR351M (fr) Nouvel antibiotique lankavacidine utilisable en thérapeutique.
OA01426A (fr) Synchro-machines perfectionnées.
DK103424C (da) Høvender.
DK120015B (da) Fluidistor.
BE595070A (fr) Plansichter.
FR353M (fr) Nouvelle quinoléine utilisable en thérapeutique.
FR310M (fr) Nouvelle aza-hexylene-imino-éthyl-guanidine utilisable en thérapeutique.
FR1233212A (fr) Cystoscope utilisable en pédiatrie
DK95557C (da) Glashus.
FR222M (fr) Nouvelle 2,5-bis-éthylene-imino-3,6-bis-acylamino-p-benzoquinone utilisable en thérapeutique.
FR348M (fr) Nouveau glucofuranoside 3,5,6-substitué utilisable en thérapeutique.
FR1029M (fr) Nouveau 17α-isobutyl-androstane-3β,17β-diol utilisable en thérapeutique.
BE596272A (fr) Nouvelle substance utilisable en thérapeutique.
FR303M (fr) Nouvelle guanidine utilisable en thérapeutique.
FR3174M (fr) Nouvel δ-3β17β-dihydroxy-7α17α-diméthyl-19-nor-androstene utilisable en thérapie.
FR163M (fr) Nouvelle phénoxy-éthylamine utilisable en thérapeutique.
BE583857A (fr) Agent opacifiant utilisable en radiologie.
FR269M (fr) Nouvelles substances antibiotiques.